Biography:
Andrey N. Belousov, MD, PhD, Professor - a Ukrainian medical scientist and pioneer in nanotechnology, who developed the world’s first biocompatible nanomedical drugs (Micromage-B, MCS-B, ICNB), officially registered and introduced into clinical practice since 1998. His work established a translational foundation for medical nanotechnology, linking fundamental biophysics with clinical applications in detoxification, hemocorrection, and neuroprotection. The published more 340 scientific works on results application of nanotechnology preparation in experimental and practical medicine. At now Andrey Belousov - the Head of Laboratory Applied Nanotechnologies, Professor of Kharkiv National Medical University, Ukraine.
Title : From biophysics to clinical application: Investigating the antibacterial potential of magnetite nanoparticles (MCS B)
Title : Selective MRI contrast with magnetite nanoparticles in malignant tumors: Hopes and challenges
Title : Application of biocompatible magnetite nanoparticles (Micro mage-B) in the complex treatment of multiple sclerosis
Title : Effect of nanotechnologically treated physiological saline solution on clinical and physiological parameters of preserved donor erythrocytes during the stages of their storage under hypothermic conditions